arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

BECTON DICKINSON & CO

BDX
$213.49 ▲ +4.39 (+2.10%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
75 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Neutral
auto_awesome

Analytical Summary

BECTON DICKINSON & CO shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $58.7B
Dividend Yield 0.49%
Revenue Growth -9.5% ↗
Op. Margin 13.3% ↗
ROIC 1.4% ↗
FCF / Share None
Trailing P/E 155.8x
Price / Book 2.4x
FCF Yield —
Debt / Equity 0.55
info Valuation on last close. End-of-day price, Nov 5, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$4.98B
↓ -9.5% —
Net Income Profit after all expenses
$377.00M
↓ -34.3% —
Operating Margin Operating profit as % of sales
13.3%
↑ +574.4% 60th
FCF / Share Free cash flow per share
$1.92
↑ +23.5% —
Long-Term Debt Long-term obligations
$13.51B
↓ -8.1% —

Health Breakdown

Profitability ↓
60
Returns ↓
58
Financial Health ↓
55

Dividend History

Dividend / share · sourced from SEC filings
$4.16 Latest / share
+9.5% YoY
+6.1% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 20 years · 75 quarters